Our therapeutic goal at Caron Treatment Centers is long-term sobriety. To achieve that goal, we use a multidisciplinary approach to address the co-occurring disorders often found with substance use. When appropriate, MAT is used as part of a comprehensive treatment and recovery plan.
Of the available FDA-approved MAT strategies, Caron utilizes naltrexone extended release (XR) or buprenorphine maintenance. Through a diligent and thoughtful process, Caron’s medical and clinical professionals chose naltrexone XR as a primary choice because it is a non-mood altering opioid receptor antagonist with no euphoric effect, no withdrawal syndrome, and no abuse or overdose potential.
Additionally, patients who relapse while taking Naltrexone XR would not be in imminent danger of respiratory arrest. To increase compliance, we administer it as a monthly injection. Learn more.